- In June 2023, Baxter, a global healthcare company, launched the Progressa Next-Gen ICU Bed, a new development aimed at addressing the complex needs of critical care. This innovative ICU bed is designed to enhance patient care by improving comfort, safety, and mobility. The Progressa bed features advanced technology that supports better patient positioning, minimizes pressure injuries, and assists healthcare professionals in managing critically ill patients more efficiently. The bed's design also enables easier access to patients for medical procedures, which can improve treatment outcomes and reduce the burden on healthcare providers. Ultimately, it is expected to enhance the overall ICU experience for both patients and healthcare teams, contributing to better care and faster recovery
- In May 2023, Option Care Health, a leader in home and alternate site infusion services, announced its merger with Amedisys, a leading provider of home health care services. This strategic combination aims to create a leading provider of integrated home-based healthcare solutions. The merger will enhance the companies' ability to offer comprehensive care, improving patient outcomes while reducing healthcare costs. By combining their resources and expertise, Option Care Health and Amedisys plan to expand their reach, providing more patients with access to high-quality home infusion and home health care services. This collaboration is expected to drive growth, improve operational efficiencies, and better address the growing demand for home-based care
- In March 2023, Fresenius Kabi, a global healthcare company, was awarded a technology breakthrough agreement with Premier Inc., a leading healthcare improvement company. This agreement focuses on enhancing the adoption of innovative healthcare technologies in hospitals and healthcare facilities. Through this collaboration, Fresenius Kabi will provide advanced medical devices and infusion technologies, improving efficiency and patient outcomes. The partnership is expected to streamline supply chains and optimize the delivery of care, benefiting both healthcare providers and patients by reducing costs and improving treatment precision. The agreement underscores Fresenius Kabi’s commitment to advancing patient care through innovative technologies and strategic partnerships
- In January 2022, ICU Medical, a global leader in infusion therapy, completed the acquisition of Smiths Medical, a division of Smiths Group plc. This strategic acquisition aims to expand ICU Medical's product portfolio and strengthen its position in the infusion and critical care markets. By integrating Smiths Medical’s extensive range of medical devices and infusion systems, ICU Medical will enhance its ability to provide innovative and high-quality solutions to healthcare providers worldwide. This merger is expected to improve patient care by offering a broader range of advanced products, streamline operational efficiencies, and drive growth in the global healthcare market. The acquisition also positions ICU Medical as a more comprehensive provider of critical care solutions, benefiting both patients and healthcare professionals
Frequently Asked Questions
The primary challenges include regulatory and reimbursement challenges and lack of skilled workforce for home care.
The infusion pumps segment is expected to dominate the global home infusion therapy market, holding a major market share in 2025.
